$0.570
-0.029 (-5.15%)Al cierre
Predicciones de precio
Ábrelo en la app para desbloquear previsiones a más largo plazo.
Predicción y previsión de HUMA por análisis de gráficos similares
Alphio's HUMA stock price prediction model matches the current Humacyte Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $0.57 (+0.42%). The 1-week path is $0.58 (+1.56%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
¿Debería comprar acciones de Humacyte Inc?
Humacyte Inc is currently priced at $0.6501, which is significantly below the analyst price targets of $1 to $4, indicating potential upside. However, the company has a high forward P/E of 35.84, suggesting that it may be overvalued relative to its earnings potential. Additionally, the recent RSI of 45.646 indicates that the stock is neither overbought nor oversold, suggesting caution. The main risk is the company's significant net income loss of -36802000 in Q2 2026, which raises concerns about its financial health.
HUMA cerró en $0.57 el Tuesday, tras bajar -5.15%
Humacyte Inc (HUMA) last closed at $0.5704, losing -5.15%. These facts feed the 1-day and 1-week HUMA price prediction above.
Factores de la previsión
Los factores de la previsión de Humacyte Inc (HUMA) combinan patrones gráficos similares, estacionalidad y medias móviles.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bearish
SMA 200
Bearish
Patrones gráficos similares
Acciones cuya trayectoria reciente más se parece a la de HUMA, ordenadas por similitud.
Análisis de estacionalidad de HUMA
Historically the probability of a positive September return for HUMA is 47.62%. February offers the highest probability of a positive month at 62.07%, while April is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.